• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

FDA Drug Shortages

  • Print
  • Share
  • E-mail
-

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

 Amikacin Injection

 Status: Currently in Shortage

 » Date first reported: No date available
 » Therapeutic Categories: Anti-Infective

Bedford Laboratories (Reverified 07/09/2014)

Company Contact Information:
800-562-4797

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
250 mg/mL; 2 mL vials (NDC 55390-0226-02) Available Check wholesaler for inventory. Other
250 mg/mL; 4 mL vials (NDC 55390-0226-04) Unavailable Shortage: Pending Manufacturing Change or Addition. Availability of products are updated on the Bedford Laboratories website Other

Heritage Pharmaceuticals Inc. (Reverified 07/17/2014)

Company Contact Information:
866-901-3784

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
250 mg/mL: 2 mL vials, package of 10 (NDC 23155-290-41) Available from March 2014 Expected new launch Other
250 mg/mL: 4 mL vials, package of 10 (NDC 23155-290-42) Available from March 2014 Expected new launch Other

Teva Pharmaceuticals (Reverified 10/06/2014)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
250 mg/mL; 2 mL vials (NDC 00703-9032-03) Teva has 2ml and 4mL vials available. Product is available and shipping Demand increase for the drug
250 mg/mL; 4 mL vials (NDC 00703-9040-03) Teva has 2ml and 4mL vials available. Product is available and shipping Demand increase for the drug
-
-